Diabetes mellitus affects approximately 37 million Americans — 11.3% of the U.S. population — and is the primary or contributing diagnosis for millions of hospital admissions, SNF stays, home health episodes, and outpatient visits annually. Effective diabetes management depends on accurate, reliable blood glucose monitoring supplies. For healthcare facilities and pharmacies managing large diabetic populations, supply standardization and procurement efficiency directly impact both patient outcomes and operational costs.
Glucometers and Point-of-Care Testing
Point-of-care blood glucose testing is performed with a handheld glucometer using a small blood sample obtained by fingerstick. Hospital and institutional glucometers differ from consumer devices in several important ways: they are designed for use across multiple patients, interface with EMR systems via barcode or RFID, and meet more stringent accuracy requirements (ISO 15197:2013 ±15% across the reportable range for CLIA-waived devices).
Major institutional glucometer platforms include: Abbott (Precision Xceed Pro), Nova Biomedical (StatStrip), Roche (Accu-Chek Inform II), and Siemens (RapidPoint). Each system uses proprietary test strips — confirming strip compatibility with your meter fleet before switching suppliers is critical.
Test Strips: The High-Volume Consumable
Blood glucose test strips are the highest-cost consumable in diabetes monitoring programs. A long-term care facility with 100 diabetic residents may use 300–500 strips per day. Procurement strategies that reduce strip cost per test — volume contracts, formulary standardization on a single strip SKU — can save tens of thousands of dollars annually without compromising care quality.
For Medicare-covered patients in home settings, test strip coverage follows specific coding requirements (A4253 for non-insulin-dependent, A4253 for insulin-dependent). Ensuring your strips carry the appropriate HCPCS codes prevents reimbursement denials.
Lancets and Lancing Devices
Safety lancets — with retractable or auto-disable mechanisms — are required for all multi-patient fingerstick testing under OSHA's Bloodborne Pathogens Standard. Single-use safety lancets (28–33 gauge) from BD, Roche, and Nipro are the standard. Lancing devices with depth adjustment reduce patient discomfort and improve compliance with self-monitoring programs.
Continuous Glucose Monitors (CGMs)
CGMs measure interstitial glucose continuously via a subcutaneous sensor, transmitting readings to a receiver or smartphone every 1–5 minutes. The three major CGM systems — Abbott FreeStyle Libre, Dexterity G6/G7, and Medtronic Guardian — are revolutionizing diabetes management by eliminating most routine fingersticks. CGMs are now covered by Medicare for all insulin-treated diabetes patients. Sensors are replaced every 7–14 days depending on the system.
Insulin Delivery Supplies
Insulin-dependent patients require syringes (29–31 gauge, 0.3–1 mL), pen needles (4–8 mm), or insulin pump infusion sets. Safety insulin syringes with retractable needles (BD AutoShield Duo, Smiths Medical) reduce needlestick risk. For facilities managing insulin pens, ensure a consistent supply of compatible pen needles matched to the pen platform in use.
Stocking a Complete Diabetes Supply Program
Healix stocks blood glucose meters, test strips, safety lancets, insulin syringes, pen needles, and CGM supplies from BD, Abbott, Roche, and Nova. For high-volume facilities, we offer case pricing and formulary standardization support. Browse our diagnostic equipment catalog or call (888) 585-6510.